There are 2934 resources available
4745 - Functional Cell Profiling (FCP) of _100,000 CTCs from multiple cancer types identifies morphologically distinguishable CTC subtypes within and between cancer types
Presenter: Adam Jendrisak
Session: Poster Discussion session - Basic science
Resources:
Abstract
2774 - HORAS5 promotes cabazitaxel resistance in castration resistant prostate cancer via a BCL2A1-dependent survival mechanism
Presenter: Perla Pucci
Session: Poster Discussion session - Basic science
Resources:
Abstract
2122 - The role of EGFR inhibitor (EGFRi) in immune cell infiltration and CD8+ T-cell activation in EGFR mutant lung cancer
Presenter: Fenge Li
Session: Poster Discussion session - Basic science
Resources:
Abstract
5436 - The mutational signature of spontaneously developing tumors in MLH1-/- mice – potential consequences for immunotherapeutic approaches
Presenter: Claudia Maletzki
Session: Poster Discussion session - Basic science
Resources:
Abstract
3759 - Identification of a Radio-Immune Signature with High Prognostic Value in Surgically Resected NSCLC
Presenter: Giulia Mazzaschi
Session: Poster Discussion session - Basic science
Resources:
Abstract
4493 - Aurora-B mediated Snail phosphorylation is essential for mitotic spindle checkpoint and for preventing chromosomal instability in breast cancer
Presenter: Bo Xu
Session: Poster Discussion session - Basic science
Resources:
Abstract
1051 - Synergistic anti-cancer activity of auranofin with anti-PD-L1 therapy in triple-negative breast cancer
Presenter: Prahlad Raninga
Session: Poster Discussion session - Basic science
Resources:
Abstract
816 - Aspartate-_-hydroxylase drives hepatocelluar carcinoma progression to metastasis fueling glutamine via HIF1_-mediated mitophagy
Presenter: Ran Xue
Session: Poster Discussion session - Basic science
Resources:
Abstract
2239 - Final efficacy results from B-F1RST, a prospective Phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
Presenter: Mark Socinski
Session: Poster Discussion – NSCLC, metastatic
Resources:
Abstract
2584 - Primary results from TAIL, a global single-arm safety study of atezolizumab (atezo) monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer (NSCLC)
Presenter: Andrea Ardizzoni
Session: Poster Discussion – NSCLC, metastatic
Resources:
Abstract